Patient communication in precision medicine trials is prone to specific failure points: complex scientific content that participants cannot easily interpret, co...
Continue reading
As we step into a new era of medical innovation, it's crucial to shine a light on diseases that have long remained in the shadows. Amyotrophic lateral sclerosis...
Continue reading
In the ever-evolving landscape of healthcare, precision medicine trials stand out as a beacon of personalised treatment, tailored to the unique genetic and envi...
Continue reading
DPharm 2023 has come to a close, and as we reflect on the sessions and insights shared, two themes clearly stood out this year: The participant experience and i...
Continue reading
In this webinar, Patrick Short, CEO of Sano Genetics, discussed opportunities to improve clinical trial patient recruitment in decentralised clinical trials (DC...
Continue reading
Genetics has become a defining factor in how clinical trials are designed, who qualifies, and how enrollment is planned. Genetic variation influences both disea...
Continue reading
Last month, our team had the pleasure of attending the European Network to Cure ALS (ENCALS) meeting, an annual gathering that brings together some of the brigh...
Continue reading
Clinical trial design and protocol development sit at the foundation of every successful study. The choices made at this stage, from study type and endpoint sel...
Continue reading
Clinical trials play a crucial role in the development of pharmaceutical and biotech products. However, unforeseen challenges can arise during the trial process...
Continue reading
Patient centricity has become increasingly important in clinical trials for ALS. In this webinar, host Paul Wicks and Cathy Collet discuss the challenges of pat...
Continue reading